Metastatic cancers in the liver
What is Metastatic cancers in the liver?
Metastatic cancers in the liver occur when cancer cells from another part of the body travel through the bloodstream or lymphatic system and grow in the liver. This is different from primary liver cancer, which starts in the liver itself. The liver is a common site for cancer to spread because it filters large amounts of blood from other organs.
The most common cancers that spread to the liver include colorectal cancer, breast cancer, lung cancer, pancreatic cancer, and stomach cancer. When cancer spreads to the liver, it keeps the name of the original cancer. For example, colon cancer that spreads to the liver is called metastatic colon cancer, not liver cancer.
Metastatic liver cancer is more common than primary liver cancer. The presence of liver metastases usually means the cancer is at an advanced stage. Early detection and monitoring through blood tests and imaging can help guide treatment decisions and track how well therapies are working.
Symptoms
- Pain or discomfort in the upper right abdomen
- Unexplained weight loss and loss of appetite
- Feeling full after eating small amounts
- Nausea and vomiting
- Fatigue and weakness
- Fever without obvious infection
- Yellowing of the skin and eyes, called jaundice
- Swelling in the abdomen from fluid buildup
- Itchy skin
- Dark urine and pale stools
Some people with early metastatic liver cancer may have no symptoms at all. Symptoms often appear only when tumors grow larger or when liver function declines. Regular monitoring is important for people with a history of cancer.
Concerned about Metastatic cancers in the liver? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Metastatic liver cancer develops when cancer cells break away from a tumor in another organ and travel to the liver. The liver receives blood from the entire digestive system, which makes it vulnerable to cancer cells circulating in the bloodstream. Risk factors include having a primary cancer diagnosis, especially cancers of the colon, rectum, breast, lung, pancreas, or stomach. Advanced stage cancers are more likely to spread to distant organs.
Other risk factors that may increase the chance of cancer spreading include tumors that are larger in size, tumors that have grown into blood vessels or lymph nodes, and certain aggressive cancer types. Treatment delays or inadequate treatment of the primary cancer can also increase the risk of metastasis. Weakened immune function may make it harder for the body to fight cancer cells that travel to new locations.
How it's diagnosed
Metastatic liver cancer is usually diagnosed through a combination of imaging tests and blood work. CT scans, MRI scans, and PET scans can show tumors in the liver and help determine their size and location. A biopsy, where a small tissue sample is removed and examined under a microscope, can confirm the diagnosis and identify the original cancer type.
Blood tests play an important role in monitoring metastatic liver cancer. Alpha Fetoprotein, or AFP, is a tumor marker that can be elevated when certain cancers spread to the liver. While AFP is most commonly associated with primary liver cancer, it can also be produced by metastatic tumors in the liver. Rite Aid offers AFP testing as an add-on to help track tumor activity and treatment response. Regular blood testing along with imaging provides a more complete picture of disease progression and helps doctors adjust treatment plans.
Treatment options
- Chemotherapy to kill cancer cells or slow their growth
- Targeted therapy drugs that attack specific cancer cell characteristics
- Immunotherapy to help the immune system recognize and fight cancer cells
- Radiation therapy to shrink tumors and reduce pain
- Surgical removal of liver metastases if tumors are limited and accessible
- Ablation procedures that destroy tumors using heat, cold, or chemicals
- Liver-directed therapies that deliver treatment directly to liver tumors
- Pain management and palliative care to improve quality of life
- Nutritional support to maintain strength and manage side effects
- Clinical trials offering access to new treatments
Need testing for Metastatic cancers in the liver? Add it to your panel.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Primary liver cancer starts in the liver cells themselves, while metastatic liver cancer begins in another organ and spreads to the liver. Metastatic liver cancer is much more common than primary liver cancer. The treatment approach depends on the type of original cancer, not where it has spread.
In most cases, metastatic liver cancer is not curable, but it can be treated and managed. Some people with limited liver metastases from certain cancers may be candidates for surgical removal, which can lead to long-term survival. Treatment goals usually focus on slowing disease progression, managing symptoms, and maintaining quality of life. Each situation is different and depends on the primary cancer type and overall health.
Alpha Fetoprotein, or AFP, is a protein that can be elevated when certain tumors grow in the liver. While AFP is most commonly linked to primary liver cancer, some metastatic cancers also produce AFP when they spread to the liver. Tracking AFP levels over time can help doctors monitor how well treatment is working. Rising levels may suggest disease progression, while falling levels often indicate treatment is effective.
Colorectal cancer is the most common cancer to spread to the liver. Other frequent sources include breast cancer, lung cancer, pancreatic cancer, stomach cancer, and esophageal cancer. Melanoma and neuroendocrine tumors can also metastasize to the liver. The liver is a common site for metastasis because it filters large volumes of blood from the entire body.
Survival with metastatic liver cancer varies widely based on many factors. These include the type of original cancer, how much it has spread, overall health status, and how well the cancer responds to treatment. Some people live for months, while others may live for several years with treatment. Modern therapies continue to improve outcomes and quality of life for many patients.
Early liver metastases often cause no symptoms at all. As tumors grow, people may notice pain or fullness in the upper right abdomen, unexplained weight loss, or fatigue. Some experience loss of appetite or feel full quickly when eating. Regular monitoring with blood tests and imaging is important for people with a history of cancer, even without symptoms.
While lifestyle changes cannot cure metastatic liver cancer, they can support overall health and treatment tolerance. Eating a nutrient-rich diet helps maintain strength and manage side effects. Staying physically active as able can improve energy and mood. Avoiding alcohol is important because it stresses the liver. Getting enough rest and managing stress also support immune function during treatment.
The frequency of tumor marker testing depends on your treatment plan and how your cancer is behaving. Many doctors check markers like AFP every few weeks to months during active treatment. More frequent testing may be needed if treatment changes or if there are concerns about disease progression. Your oncology team will recommend a monitoring schedule based on your individual situation.
Surgery can be an option for some people with limited liver metastases from certain cancers, particularly colorectal cancer. Ideal candidates typically have a small number of tumors that can be safely removed and good overall health. The primary cancer should be controlled or treatable. Surgical removal of liver metastases can lead to long-term survival in selected patients, but most cases are managed with systemic therapies.
Ask about the extent of the metastases and how they were detected. Find out what treatment options are available and what the goals of treatment are. Ask about expected side effects and how they can be managed. Discuss how treatment will be monitored, including blood tests and imaging schedules. Understanding your prognosis and quality of life expectations can help you make informed decisions about your care.